Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
The transaction is expected to close in the Q4FY22
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
AstraZeneca, Sinopharm and Moderna were part of the study
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Subscribe To Our Newsletter & Stay Updated
